Moomoo AI 已提取核心訊息
On December 31, 2023, Zheng Wei, a United States citizen, filed an amended Schedule 13G/A with the Securities and Exchange Commission, disclosing a significant stake in Connect Biopharma Holdings Limited. The filing indicates that Zheng Wei holds beneficial ownership of 6,487,545 ordinary shares of Connect Biopharma, representing 11.7% of the company. This ownership includes 5,928,164 ordinary shares and 559,381 shares underlying stock options exercisable as of March 1, 2024. The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934. Connect Biopharma, with its principal executive offices located in San Diego, California, trades its ordinary shares in the form of American Depositary Shares (ADSs), each representing one ordinary share, under the CUSIP number 207523101.
On December 31, 2023, Zheng Wei, a United States citizen, filed an amended Schedule 13G/A with the Securities and Exchange Commission, disclosing a significant stake in Connect Biopharma Holdings Limited. The filing indicates that Zheng Wei holds beneficial ownership of 6,487,545 ordinary shares of Connect Biopharma, representing 11.7% of the company. This ownership includes 5,928,164 ordinary shares and 559,381 shares underlying stock options exercisable as of March 1, 2024. The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934. Connect Biopharma, with its principal executive offices located in San Diego, California, trades its ordinary shares in the form of American Depositary Shares (ADSs), each representing one ordinary share, under the CUSIP number 207523101.
2023年12月31日，美國公民鄭偉向美國證券交易委員會提交了經修訂的附表13G/A，披露了康尼特生物製藥控股有限公司的大量股份。該文件顯示，正威持有康尼特生物製藥6,487,545股普通股的實益所有權，佔該公司的11.7％。該所有權包括截至2024年3月1日可行使的5,928,164股普通股和559,381股標的股票期權。該文件是根據1934年《證券交易法》第13d-1（c）條提交的。Connect Biopharma的主要執行辦公室位於加利福尼亞州聖地亞哥，以美國存托股（ADS）的形式交易普通股，每股代表一股普通股，CUSIP編號爲207523101。
2023年12月31日，美國公民鄭偉向美國證券交易委員會提交了經修訂的附表13G/A，披露了康尼特生物製藥控股有限公司的大量股份。該文件顯示，正威持有康尼特生物製藥6,487,545股普通股的實益所有權，佔該公司的11.7％。該所有權包括截至2024年3月1日可行使的5,928,164股普通股和559,381股標的股票期權。該文件是根據1934年《證券交易法》第13d-1（c）條提交的。Connect Biopharma的主要執行辦公室位於加利福尼亞州聖地亞哥，以美國存托股（ADS）的形式交易普通股，每股代表一股普通股，CUSIP編號爲207523101。
有用
沒用